Skip to main content
OpenTrials

Clinical trial condition

Chronic Myelogenous Leukemia

Explore clinical trials studying Chronic Myelogenous Leukemia. Study availability and eligibility vary by location and protocol.

112 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Chronic Myelogenous Leukemia trial results

Completed

Study of BMS-354825 in Subjects With CML Who Are Resistant to or Intolerant of Imatinib or Ph+All in Japan

NCT00337454

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +11 more
Locations
  • Local Institution Nagoya, Aichi-ken, Japan
  • Local Institution Nagoya, Aichi-ken, Japan
  • Local Institution Nagoya, Aichi-ken, Japan
  • Local Institution Maebashi, Gunma, Japan
View all 21 locations
View Trial Details
Completed

Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Chronic Phase Who Are Refractory to Imatinib Mesylate (Gleevec)

NCT00042016

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +11 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Scripps Clinic Escondido, California, United States
  • USC/Norris Cancer Center Los Angeles, California, United States
  • Metro-Minnesota CCOP Saint Louis Park, Minnesota, United States
View Trial Details
Completed

Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Accelerated Phase Who Are Refractory to Imatinib Mesylate (Gleevec)

NCT00041990

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +11 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Scripps Clinic Escondido, California, United States
  • USC/Norris Cancer Center Los Angeles, California, United States
  • Metro-Minnesota CCOP Saint Louis Park, Minnesota, United States
View Trial Details
Completed

Infusion of Specially Treated Umbilical Cord Stem Cells After Chemoradiation Treatment for Blood Cancers

NCT00089596

Conditions
Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +25 more
Locations
  • Loyola University Medical Center Maywood, Illinois, United States
  • Indiana University Cancer Center Indianapolis, Indiana, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
View Trial Details
Active, Not Recruiting

HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide

NCT04904588

Conditions
Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, +30 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Stanford University Stanford, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
View all 39 locations
View Trial Details

Related conditions